The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quality of life (QoL) and symptoms evaluation in metastatic breast cancer (MBC) patients (pts) treated with eribulin: Preliminary results of a prospective observational study.
Teresa Gamucci
No relevant relationships to disclose
Lucia Mentuccia
No relevant relationships to disclose
Silvia Quadrini
No relevant relationships to disclose
Luca I. Moscetti
No relevant relationships to disclose
Patrizia Vici
No relevant relationships to disclose
Isabella Sperduti
No relevant relationships to disclose
Laura Pizzuti
No relevant relationships to disclose
Daniela Franco
No relevant relationships to disclose
Maria Anna Giampaolo
No relevant relationships to disclose
Maria Agnese Fabbri
No relevant relationships to disclose